Grip Healthcare Social Media
Grip Healthcare Social Media
Grip Healthcare Social Media
JANUARY 8, 2 010
IntroductIon
This document is intended to provide Grips high-level perspective and approach on developing a social media strategy for Pharmaceutical Marketing in Canada. In addition, we attended the PAAB seminar on social media held in Toronto on September 30, 2009 and have included key elements into our framework for your consideration. Before discussing a point of view on the rules of engagement between pharmaceutical marketing and social media it is important to baseline the term social media. For the purpose of this document, we will define social media as content that is created on the Internet by the public and not produced by journalists, editors or media conglomerates. Some examples of this type of online content include discussion forums, blogs, MySpace and, more recently, content on Facebook and Twitter. This space is relatively new and will continue to evolve as attitudes and preferences shift, but the basic premise (of content created by regular users and not publishing professionals) should remain consistent for the foreseeable future. Businesses today leverage the power of social media in its various forms as they apply to marketing strategies, typically based on the nature of the business and its goals. For example, Best Buy is currently using Twitter (www.twitter.com/bestbuy) to provide knowledge and technical support to their customers. General Motors is using a blog format (http://fastlane.gmblogs.com) so their CEO can connect and communicate regularly with the general public. In each of these examples, both companies spent time assessing their customers online habits and then developed a social media strategy that aligned with their marketing goals.
Figure 1.0
Actively listening to your customer base will help you to understand where they fit on the social technographics ladder outlined in Fig. 2.0. The ladder provides a general indication of the types of users online and is subject to change as social media evolves. For example, the percentage of content creators will exceed 13% as people become more comfortable uploading personal content to social networking and other user-content based websites.
The technographics ladder can be used to map segmented personas of your customer base. It will provide a quick snapshot that can help you determine if your customer base is high content creators (those who love to post pictures and tell stories), or if they are spectators (people who prefer to watch passively from the sidelines). In either case, each marketing vertical has specific considerations and anomalies, and this is especially true in Pharma marketing.
Fig. 3.0 provides an additional lens to further assess the best social media approach based on patient condition. The research below shows that patients with certain conditions rank higher on the social technographics ladder. For example, patients with obesity tend to share more online than do patients suffering from diabetes. This does not imply that diabetes treatment marketers should disqualify using social media as a tool, but instead that the strategy and technology tactics used to engage this group would be different than with patients suffering from obesity.
3.
Engage PAAB and/or ASC as soon as you have a draft idea. As with any new campaign, its best to have a quick call with PAAB and/or ASC to walk them through a draft concept in order to get their input early. Waiting to do so until youve fully planned and designed the experience may be costly and will take longer during the review period.
4. Ensure that you have the right resources and training in place to monitor and react to user comments in a timely manner. This role is key. This person must have a solid knowledge base of the legal conditions and sufficient time to monitor and participate in the dialog.
to Sum up
Yesterday, brands told stories. Today, consumers tell stories about your brands. Pharmaceutical companies that work to incorporate social media as part of their long-term marketing vision will start to create the foundations toward earning their seat at the table to participate and listen to these high-value conversations about their brands. Businesses today leverage the power of social media in its various forms as it applies to marketing strategies, typically based on the nature of the business and its goals. Although the process of pharmaceutical companies integrating with social media is a little more involved, we believe the benefits outweigh the regulatory efforts required to set up social media. We hope this document has provided insight on how some businesses can approach social media and also shed some light on how pharmaceutical companies in Canada can engage in social media while remaining compliant with Health Canada regulations. If you would like further information on any of the topics discussed, or assistance developing a social media strategy for your brand, please contact:
Kristina Hayes Director, Business Interactive Grip Limited 179 John Street, 6th Floor Toronto, Ontario M5T 1X4 (p) 416 204 7720 [email protected]
Holly Broome Manager, Business Grip Limited 179 John Street, 6th Floor Toronto, Ontario M5T 1X4 (p) 416 341 7208 [email protected]